BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6975158)

  • 1. Predictive ability of Lukes-Collins classification for immunologic phenotypes of childhood non-Hodgkin lymphoma: an institutional series and literature review.
    Crist WM; Kelly DR; Ragab AH; Roper M; Dearth JC; Castleberry RP; Flint A
    Cancer; 1981 Nov; 48(9):2070-5. PubMed ID: 6975158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
    Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
    Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow and blood involvement by lymphoma in relationship to the Lukes--Collins classification.
    Foucar K; McKenna RW; Frizzera G; Brunning RD
    Cancer; 1982 Mar; 49(5):888-97. PubMed ID: 6977408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ; Frizzera G; Kersey JH; Goldman AI
    N Engl J Med; 1979 Sep; 301(10):512-8. PubMed ID: 313510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of childhood leukemia and lymphoma.
    Kersey JH; Gajl-Peczalska KJ; Coccia PF; Nesbit ME
    Am J Pathol; 1978 Feb; 90(2):487-95. PubMed ID: 304675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lukes-Collins classification and its significance.
    Lukes RJ; Collins RD
    Cancer Treat Rep; 1977 Sep; 61(6):971-9. PubMed ID: 302740
    [No Abstract]   [Full Text] [Related]  

  • 7. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and patterns of bone marrow and blood involvement by lymphoma in relationship to the Lukes-Collins classification.
    Foucar K; McKenna RW; Frizzera G; Brunning RD
    Blood; 1979 Dec; 54(6):1417-22. PubMed ID: 315803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [B-cell lymphomas (non-Hodgkin's lymphomas of B type) in children--morphologic and immunologic spectrum].
    Schwarze EW; Pileri S; Stein H; Palestro G; Tolksdorf G
    Klin Padiatr; 1982; 194(4):226-32. PubMed ID: 6982372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lukes-Collins and Kiel classifications for non-Hodgkin lymphomas. A retrospective study considering both classifications and their relationships to stage, sex, age, and survival.
    Blanco G; Alavaikko M; Apaja-Sarkkinen M; Taskinen PJ
    Anticancer Res; 1986; 6(2):267-79. PubMed ID: 3707063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new functional interpretation of malignant lymphomas. The Lukes-Collins classification and its basis].
    Maurer R; Lukes RJ
    Schweiz Med Wochenschr; 1979 Jan; 109(3):76-86. PubMed ID: 310578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent views on the functional histological classification of malignant lymphomas].
    Guarino M; Caldara G
    Arch Sci Med (Torino); 1975; 132(1):1-8. PubMed ID: 1080409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.
    Garvin AJ; Simon RM; Osborne CK; Merrill J; Young RC; Berard CW
    Cancer; 1983 Aug; 52(3):393-8. PubMed ID: 6344979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.
    Cossman J; Jaffe ES; Fisher RI
    Cancer; 1984 Oct; 54(7):1310-7. PubMed ID: 6380700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic markers of non-Hodgkin's lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Recent Results Cancer Res; 1978; 64():138-45. PubMed ID: 366692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas.
    Jaffe ES; Strauchen JA; Berard CW
    Am J Clin Pathol; 1982 Jan; 77(1):46-9. PubMed ID: 7055097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of surface markers in non-Hodgkin's lymphoma by using anti-T and anti-B lymphocyte sera.
    Yamanaka N; Ishii Y; Koshiba H; Mikuni C; Ogasawara M; Kikuchi K
    Cancer; 1981 Jan; 47(2):311-8. PubMed ID: 7006795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.